Support By : Li-lab
| PATHWAY_NAME | REACTOME_ID | KEGG_ID | DRUG_NAME | PUBCHEM_CID | Datasource |
|---|---|---|---|---|---|
| Colorectal cancer | R-HSA-4791275 | map05210 | apigenin | 448949 | drug-path |
| Type I diabetes mellitus | R-HSA-5683209 | map04940 | apigenin | 448949 | drug-path |
| Apoptosis | R-HSA-109581 | map04210 | dl-alpha tocopherol | 2116 | drug-path |
| Hedgehog signaling pathway | R-HSA-5358351 | map04340 | dl-alpha tocopherol | 2116 | drug-path |
| MAPK signaling pathway | R-HSA-9652817 | map04010 | dl-alpha tocopherol | 2116 | drug-path |
| Gap junction | R-HSA-190861 | map04540 | dl-alpha tocopherol | 2116 | drug-path |
| Calcium signaling pathway | R-HSA-381753 | map04020 | dl-alpha tocopherol | 2116 | drug-path |
| GnRH signaling pathway | R-HSA-168638 | map04912 | dl-alpha tocopherol | 2116 | drug-path |
| Vascular smooth muscle contraction | R-HSA-445355 | map04270 | dl-alpha tocopherol | 2116 | drug-path |
| Phosphatidylinositol signaling system | R-HSA-1280215 | map04070 | dl-alpha tocopherol | 2116 | drug-path |
| Neuroactive ligand-receptor interaction | R-HSA-5632681 | map04080 | dl-alpha tocopherol | 2116 | drug-path |
| Pathways in cancer | R-HSA-9824443 | map05200 | dl-alpha tocopherol | 2116 | drug-path |
| Olfactory transduction | R-HSA-9751605 | map04740 | dl-alpha tocopherol | 2116 | drug-path |
| Epithelial cell signaling in Helicobacter pylori infection | 0 | map05120 | dl-alpha tocopherol | 2116 | drug-path |
| p53 signaling pathway | R-HSA-168638 | map04115 | dl-alpha tocopherol | 2116 | drug-path |
| Renal cell carcinoma | R-HSA-9794523 | map05211 | convolamine | 420422 | drug-path |
| Olfactory transduction | R-HSA-9751605 | map04740 | convolamine | 420422 | drug-path |
| Systemic lupus erythematosus | R-HSA-977105 | map05322 | convolamine | 420422 | drug-path |
| RNA polymerase | R-HSA-73864 | map03020 | convolamine | 420422 | drug-path |
| Amyotrophic lateral sclerosis (ALS) | Q8NDH6-2 | 0 | convolamine | 420422 | drug-path |